Mirtazapine and hyperpigmentation.
Mendhekar
Dattatreya
D
Inamdar
Amir
A
D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000009:adverse effects*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D017484:Dermatitis, Phototoxic / Q000209:etiology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000078785:Mirtazapine
D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine